Literature DB >> 23437876

Mechanisms of inappropriate defibrillator therapy in a modern cohort of remotely monitored patients.

Hemal Shah1, Ure Mezu, Divyang Patel, Susan Flanigan, Haitham Hreybe, Evan Adelstein, Sandeep Jain, Volker Lang, Samir Saba.   

Abstract

INTRODUCTION: Defibrillator (ICD) technology and monitoring are evolving rapidly. We investigated the mechanisms of inappropriate ICD therapies in a modern cohort of patients followed at our institution via remote monitoring.
METHODS: From September 2009 to March 2011, a total of 2,050 ICD patients (19,600 patient-months) were remotely followed. All events (shocks and antitachycardia pacing) were adjudicated by arrhythmia specialists.
RESULTS: A total of 249 patients received ICD therapy (34% inappropriate therapy). Inappropriate ICD shocks affected 33 (1.6%) patients. There were a total of 249 inappropriate episodes in 85 patients. Supraventricular tachycardia (SVT) with 1:1 atrioventricular association was the predominant mechanism accounting for 133 episodes in 50 patients, followed by atrial fibrillation (97 episodes in 27 patients). T-wave oversensing (16 episodes in five patients), electromagnetic interference (two episodes in two patients), and ectopic beats (one episode in one patient) accounted for a small proportion of events. There were 35 arrhythmic episodes in five patients that could not be classified, all in patients with single-chamber devices. There were no differences in these results by device manufacturer.
CONCLUSIONS: Despite many technological advances, inappropriate ICD shocks still occur but at very low rates and SVT with 1:1 atrioventricular association represents their most common mechanism. ©2013, The Authors. Journal compilation ©2013 Wiley Periodicals, Inc.

Entities:  

Mesh:

Year:  2013        PMID: 23437876     DOI: 10.1111/pace.12101

Source DB:  PubMed          Journal:  Pacing Clin Electrophysiol        ISSN: 0147-8389            Impact factor:   1.976


  3 in total

1.  Electromagnetic interference in implantable cardioverter defibrillators: present but rare.

Authors:  Gesa von Olshausen; Ina-Christine Rondak; Carsten Lennerz; Verena Semmler; Christian Grebmer; Tilko Reents; Sonia Ammar-Busch; Alessandra Buiatti; Felix Bourier; Isabel Deisenhofer; Christof Kolb
Journal:  Clin Res Cardiol       Date:  2016-01-29       Impact factor: 5.460

2.  Life-threatening and life-saving inappropriate implantable cardioverter defibrillator shocks.

Authors:  Jordi Pérez-Rodon; David Doiny; Berta Miranda; Nuria Rivas-Gandara; Ivo Roca-Luque; Jaume Francisco-Pascual; Rosa Maria Lidón; David García-Dorado; Angel Moya Mitjans
Journal:  Clin Case Rep       Date:  2017-03-08

3.  Implantable cardioverter defibrillator and inappropriate therapy: "black box" examination yielded both human and technical causes.

Authors:  Antoine Kossaify
Journal:  Clin Med Insights Case Rep       Date:  2013-12-02
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.